Nu-Med Plus Inc
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers; a mobile rechargeable device to deliver nitric oxide gas; and a nitric ox… Read more
Nu-Med Plus Inc (NUMD) - Total Assets
Latest total assets as of September 2025: $5.05K USD
Based on the latest financial reports, Nu-Med Plus Inc (NUMD) holds total assets worth $5.05K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nu-Med Plus Inc - Total Assets Trend (2014–2024)
This chart illustrates how Nu-Med Plus Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nu-Med Plus Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Nu-Med Plus Inc's total assets of $5.05K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Nu-Med Plus Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nu-Med Plus Inc's current assets represent 100.0% of total assets in 2024, an increase from 80.8% in 2014.
- Cash Position: Cash and equivalents constituted 25.3% of total assets in 2024, down from 26.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Nu-Med Plus Inc Competitors by Total Assets
Key competitors of Nu-Med Plus Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Nu-Med Plus Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nu-Med Plus Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nu-Med Plus Inc is currently not profitable relative to its asset base.
Nu-Med Plus Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.02 | 0.03 | 6.72 |
| Quick Ratio | 0.02 | 0.03 | 6.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-258.66K | $ -204.54K | $ 457.48K |
Nu-Med Plus Inc - Advanced Valuation Insights
This section examines the relationship between Nu-Med Plus Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 49.86 |
| Latest Market Cap to Assets Ratio | 216.87 |
| Asset Growth Rate (YoY) | -30.3% |
| Total Assets | $9.37K |
| Market Capitalization | $2.03 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Nu-Med Plus Inc's assets at a significant premium ( 216.87x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Nu-Med Plus Inc's assets decreased by 30.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nu-Med Plus Inc (2014–2024)
The table below shows the annual total assets of Nu-Med Plus Inc from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.37K | -30.34% |
| 2023-12-31 | $13.46K | -83.08% |
| 2022-12-31 | $79.55K | +258.91% |
| 2021-12-31 | $22.16K | -96.02% |
| 2020-12-31 | $557.13K | +1117.01% |
| 2019-12-31 | $45.78K | -89.18% |
| 2018-12-31 | $423.02K | +4.01% |
| 2017-12-31 | $406.72K | -99.99% |
| 2017-09-30 | $3.45 Billion | +9707937.60% |
| 2016-12-31 | $35.53K | -100.00% |
| 2016-09-30 | $3.11 Billion | +4100050.11% |
| 2015-12-31 | $75.94K | -100.00% |
| 2015-09-30 | $1.54 Billion | +722425.84% |
| 2014-12-31 | $213.06K | -- |